SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-076594
Filing Date
2023-06-30
Accepted
2023-06-30 06:03:21
Documents
12
Period of Report
2023-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320288d1_8k.htm   iXBRL 8-K 27345
  Complete submission text file 0001104659-23-076594.txt   199462

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20230630.xsd EX-101.SCH 2989
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20230630_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20230630_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320288d1_8k_htm.xml XML 3493
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 231059281
SIC: 2834 Pharmaceutical Preparations